首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
severe osteoporosis相关文献:
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P.
Lancet. 2018 Jan 20;391(10117):230-240. doi: 10.1016/S0140-6736(17)32137-2. Epub 2017 Nov 9.
PMID:29129436
Management of severe osteoporosis.
Miller PD.
Expert Opin Pharmacother. 2016;17(4):473-88. doi: 10.1517/14656566.2016.1124856. Epub 2015 Dec 23.
PMID:26605922
Current Status of the Diagnosis and Management of Osteoporosis.
Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo DF, Carcelén-Fraile MDC, López-Ruiz E.
Int J Mol Sci. 2022 Aug 21;23(16):9465. doi: 10.3390/ijms23169465.
PMID:36012730
Update on Osteoporosis Screening and Management.
Anam AK, Insogna K.
Med Clin North Am. 2021 Nov;105(6):1117-1134. doi: 10.1016/j.mcna.2021.05.016. Epub 2021 Sep 8.
PMID:34688418
Osteoporosis. Definition and clinical presentation.
Glaser DL, Kaplan FS.
Spine (Phila Pa 1976). 1997 Dec 15;22(24 Suppl):12S-16S. doi: 10.1097/00007632-199712151-00003.
PMID:9431639
Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis.
Ebina K, Etani Y, Noguchi T, Nakata K, Okada S.
J Bone Miner Metab. 2025 Jan;43(1):3-9. doi: 10.1007/s00774-024-01536-0. Epub 2024 Jul 15.
PMID:39009890
Similarities and differences between European guidelines for the management of postmenopausal osteoporosis.
Cortet B, Guañabens N, Brandi ML, Siggelkow H.
Arch Osteoporos. 2024 Sep 5;19(1):84. doi: 10.1007/s11657-024-01441-z.
PMID:39235671
Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis.
Gao S, Zhao Y.
Qual Life Res. 2023 Jun;32(6):1551-1565. doi: 10.1007/s11136-022-03281-1. Epub 2022 Nov 16.
PMID:36383282
The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracture.
Geusens P, Van Hul W, van den Bergh J, Lems W.
Expert Opin Drug Discov. 2025 Dec;20(12):1475-1492. doi: 10.1080/17460441.2025.2594642. Epub 2025 Nov 30.
PMID:41284968
Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis.
Long G, Liu C, Liang T, Zhang Z, Qin Z, Zhan X.
J Orthop Surg Res. 2023 Aug 5;18(1):574. doi: 10.1186/s13018-023-04051-6.
PMID:37543616
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3